Prognosis

As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing to catch up. Prognosis explores the leading edge of medical advances, and asks who gets—or should get—access to them. We look at how innovation happens, when it fails, and what it means to the people with a disease trying to feel better, live longer, or avoid death.
Subscribe via Apple Podcasts
Some patients can't wait for pharmaceutical companies to develop drugs. They're pushing the drug industry to make the cures they and their loved ones…
Should a patient dying of a disease with no proven cure have the right to try whatever experimental drug they want? A controversial new law signed by…
When you pick up your prescription at the pharmacy, do you ever wonder how that pill made it your way? Who discovered it? Who believed in it when no …
Researchers and pharmaceutical companies have poured time and money into developing an effective drug to combat obesity. But time and again, the drug…
Eighteen years ago, scientists decoded the human genome. But what was supposed to create an era of new cures didn't work out that way, at least not a…
In episode three of Prognosis, Kristen V. Brown and Sarah McBride take a trip to Burning Man. They're there to follow Rick Doblin, who has become som…
If you had told people from the 1970s that few decades later the globe would be connected with powerful computers held in the palm of your hand, they…
More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone tha…
For all episodes, subscribe via iTunes